PLX

Protalix BioTherapeutics (DE) (PLX)

About Protalix BioTherapeutics (DE) (PLX)

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Details

Daily high

$1.78

Daily low

$1.71

Price at open

$1.73

52 Week High

$1.90

52 Week Low

$0.82

Market cap

129.6M

Dividend yield

0.00%

Volume

344,361

Avg. volume

373,775

P/E ratio

-12.38

Protalix BioTherapeutics (DE) News